The Epstein-Barr virus LMP2A protein was expressed in a human keratinocyte cell line, HaCaT, and effects on epithelial cell growth were detected in organotypic raft cultures and in vivo in nude mice. Raft cultures derived from LMP2A-expressing cells were hyperproliferative, and epithelial differentiation was inhibited. The LMP2A-expressing HaCaT cells were able to grow anchorage independently and formed colonies in soft agar. HaCaT cells expressing LMP2A were highly tumorigenic and formed aggressive tumors in nude mice. The LMP2A tumors were poorly differentiated and highly proliferative, in contrast to occasional tumors that arose from parental HaCaT cells and vector control cells, which grew slowly and remained highly differentiated. Animals injected with LMP2A-expressing cells developed frequent metastases, which predominantly involved lymphoid organs. Involucrin, a marker of epithelial differentiation, and E-cadherin, involved in the maintenance of intercellular contact, were downregulated in LMP2A tumors. Whereas activation of the mitogen-activated protein kinase pathway was not observed, phosphatidylinositol-3-kinase (PI3-kinase)-dependent activation of the serine-threonine kinase Akt was detected in LMP2A-expressing cells and LMP2A tumors. Inhibition of this pathway blocked growth in soft agar. These data indicate that LMP2A greatly affects cell growth and differentiation pathways in epithelial cells, in part through activation of the PI3-kinase-Akt pathway.
Epstein-Barr virus (EBV) is a ubiquitous herpesvirus of the familyGammaherpesviridae. Primary infection occurs in the oropharyngeal epithelium, which is permissive for virus replication. Trafficking B lymphocytes are subsequently infected by progeny virions that go on to establish a lifelong latent infection in the B-cell compartment with periodic reactivation and reinfection of the oropharyngeal epithelium, virus release, and transmission of virus via the salivary route (27). EBV is associated with a number of human malignancies, such as Burkitt's lymphoma, Hodgkin's lymphoma, posttransplant lymphoproliferative disease, and the epithelial cell malignancy nasopharyngeal carcinoma (NPC) (27,42,(44)(45)(46)56). In EBV latency, only a subset of genes is expressed. Different types of latency can be distinguished according to the latent gene products expressed. In type I latency, characteristic of Burkitt's lymphoma, only the EBV nuclear antigen 1 (EBNA1), transcripts from the BamHI-A region of the genome (10), and the EBERs, small, nonpolyadenylated RNAs with an unknown function, are expressed. In B-cell lines immortalized by EBV in vitro, all latent genes are expressed, which include EBNA1 through -6, BamHI-A transcripts, EBERs, and three latent membrane proteins, LMP1, LMP2A, and LMP2B (latency III). The pattern of gene expression is more restricted in NPC, with expression of EBNA1, EBERs, BamHI-A transcripts, and the latent membrane proteins (latency II) (27).LMP2A and -2B arise from two different promoters, and transcription proceeds across the fused ...